Clinical trial · no report yet · Phase 1
MajesTEC-2
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
- NCT04722146 ↗
- Active not recruiting
- Janssen Research & Development, LLC
- 31 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| Podcasts | 17 | |
| YouTube | 11 | |
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- A Multi-arm Phase 1b Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
- Phase
- Phase 1
- Status
- Active not recruiting
- Conditions
- Multiple Myeloma
- Interventions
- Teclistamab; Daratumumab; Pomalidomide; Lenalidomide; Bortezomib; Nirogacestat
- Arms
- Treatment Regimen A: Teclistamab + Daratumumab + Pomalidomide · Experimental
- Treatment Regimen B: Teclistamab + Daratumumab + Lenalidomide + Bortezomib (21-day Cycles) · Experimental
- Treatment Regimen C: Teclistamab + Nirogacestat · Experimental
- Treatment Regimen D: Teclistamab + Lenalidomide · Experimental
- Treatment Regimen E: Teclistamab + Daratumumab + Lenalidomide · Experimental
- Treatment Regimen F: Teclistamab + Daratumumab + Lenalidomide + Bortezomib (28-day Cycles) · Experimental
- Enrollment
- 140
- Primary outcomes
- Number of Participants with Incidence of Adverse Events (AEs)
- Number of Participants with AEs by Severity
- Number of Participants with Abnormalities in Laboratory Values
- Number of Participants with Dose-Limiting Toxicity (DLT)
- Sponsor
- Janssen Research & Development, LLC
- Start
- Mar 12, 2021
- Primary completion
- Oct 3, 2025
- Results posted
- No
- Registry record
- NCT04722146 · updated Sep 28, 2026